Daniele Compagnone

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

Daniel E. Furst, Michael Schiff, Roy Fleischmann et al. · PubMed · 2003 · 494 citations

Randomized European Multicenter Trial of Surfactant Replacement Therapy for Severe Neonatal Respiratory Distress Syndrome: Single Versus Multiple Doses of Curosurf

Christian P. Speer, Bengt Robertson, Tore Curstedt et al. · PEDIATRICS · 1992 · 208 citations

Acute Lung Injury, Surfactant Treatment, Neonatology +12

Urinary caffeine metabolites in man

D. Ullrich, Daniele Compagnone, B. Münch et al. · European Journal of Clinical Pharmacology · 1992 · 36 citations

Urinary Caffeine Metabolites, Urology, Metabolomic Profiling +4

Factors Influencing Morbidity and Mortality in Infants with Severe Respiratory Distress Syndrome Treated with Single or Multiple Doses of a Natural Porcine Surfactant

Egbert Herting, C P Speer, Kristian Harms et al. · Neonatology · 1992 · 33 citations

Verapamil SR and trandolapril combination therapy in hypertension—a clinical trial of factorial design

J. Scholze, Peter Zilles, Daniele Compagnone · British Journal of Clinical Pharmacology · 1998 · 23 citations · Full text